Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2026-01-07 @ 5:27 PM
Study NCT ID:
NCT05549661
Status:
RECRUITING
Last Update Posted:
2025-02-14
First Post:
2022-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Sponsor:
Organization: